glp-1 cv outcome trials Emerging Frontiers in Therapeutics: A Comprehensive Evidence Base (2025) What Are GLP-1 Medications? Complete

Glucagon-like-peptide-1 (GLP-1) agonists are a group of drugs approved for use in management of type-2 diabetes and obesity

Visit our FAQ

Wegovy, Ozempic, Mounjaro, weight loss pills, GLP-1s, incretinsthese terms are used interchangeably (and often incorrectly) to describe a class of medications approved to treat diabetes and, more recently, obesity

Good news you may qualify

This platform enables the functional screening and profiling of compounds that modulate gut hormone secretion and nutrient sensing, accelerating innovation in the treatment of metabolic disorders

Ghosal S, Datta D, Sinha B (2021) A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D)